Searched for
DILIP SHANGHVI ACQUISITIONS
Sun Pharma: How a small Kolkata trader became a global buyout artistSun Pharma, led by Dilip Shanghvi, is poised for its largest overseas acquisition, a $12.5 billion deal for Organon & Co. This move continu...27 Apr, 2026, 02.24 PM IST- Sun Pharma shares jump over 9% after firm announces $12 billion Organon acquisitionSun Pharmaceutical Industries' shares surged after announcing the $11.75 billion acquisition of US-based Organon & Co., a global leader in ...27 Apr, 2026, 10.33 AM IST
- ET Exclusive | Sun Pharma set to acquire Organon for $12.5 bn, its biggest till dateUS company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai H...27 Apr, 2026, 08.52 AM IST
- Sun Pharma looks to outshine rival bids with $13 billion Organon offerSun Pharmaceutical is making its biggest move yet with a $13 billion offer for Organon & Co. This ambitious bid aims to transform the India...24 Apr, 2026, 08.17 AM IST
- Sun Pharma to stay disciplined on M&A, says Dilip ShanghviSun Pharma plans a careful acquisition strategy. The company prioritizes organic growth to remain an attractive investment. Chairman Dilip ...08 Feb, 2026, 11.46 AM IST
- Sun Pharma eyes acquisitions in US, Europe and emerging marketsWith a market share of 8.1% as per market research firm AIOCD-AWACS in September 2021, Sun Pharma has the highest share in the domestic pha...03 Nov, 2021, 07.04 AM IST
- Sun Pharma looks at acquisitions in US, Europe & emerging marketsDilip Shanghvi, managing director of Sun Pharma told analysts at the company's earnings call on Tuesday that the drug maker is interested i...02 Nov, 2021, 09.21 PM IST
- Dilip Shanghvi, promoters to make open offer to buy 26% Suzlon stakeDilip Shanghvi- controlled entities along with promoters of Suzlon will make an open offer worth Rs 2,837 crore to acquire 26% stake in the...16 Dec, 2015, 10.56 PM IST
- Here's a snapshot of Sun Pharmaceutical's acquisitions and turnaround storiesExperts say there are three key tests — a substantial improvement opportunity, strategic fit for existing businesses and reasonable price.21 Sep, 2015, 04.47 AM IST
- Open to acquisitions but selective with targets: Sun PharmaSun Pharma says it is open to further acquisitions but will consider only targets "which will not require significant amount of management ...31 May, 2015, 01.15 PM IST
- Competition Commission approves Dilip Shanghvi's proposed Rs 1,800-crore deal with SuzlonThe deal, announced in February this year, would see Shanghvi acquiring at least 23 per cent stake in Suzlon which has been grappling with ...08 May, 2015, 09.23 PM IST
- Sun Pharma surges on reports Shanghvi likely to buy partial stake of Daiichi in company; ends day flatSun Pharma rose as much as 2.8 per cent to hit its intraday high of Rs 1066.40 on the BSE, after ET NOW reported the story.20 Apr, 2015, 04.14 PM IST
- Need to regain trust of regulators post Ranbaxy deal: Dilip Shanghvi, Sun PharmaIn an interview with ET Now, Nirmal Jain, chairman, IIFL Group, and R Venkataraman, managing director, share their views on markets.26 Mar, 2015, 01.27 PM IST
- Dilip Shanghvi, Sun Pharma promoter, a pharma maven with midas touchThe only investment which has not yet borne fruit for Shanghvi is his stake in BioLight Israeli Life Sciences Investments, which is listed ...16 Mar, 2015, 11.16 AM IST
- ET Awards 2014: Sun Pharma's Dilip Shanghvi is Business Leader of the yearThe low-key, but persistent, managing director of Sun Pharmaceutical Industries is a self-made billionaire.01 Oct, 2014, 09.39 AM IST
- Ranbaxy deal fabulous for Sun Pharma: Ajay PiramalSun Pharma will be in a better position to manage Ranbaxy. They have handled overseas acquisitions successfully, says Ajay Piramal.08 Apr, 2014, 02.05 AM IST
- As valuations dip, Sun Pharma is in M&A modeBe it the slowdown of 2001, or that of 2008, good pharma companies in India have continued to grow well with historically high margins, acc...16 Feb, 2009, 04.27 AM IST
Load More
